Normal Values in Stress Echocardiographic Parameters in Patients After Successful Mitral Valve Repair for Organic MR (SEP)

December 27, 2015 updated by: S.A.J. Chamuleau, UMC Utrecht

SEP-study; The Assessment of Normal Values in Stress Echocardiographic Parameters in Patients After Successful Mitral Valve Repair for Organic Mitral Valve Regurgitation

Surgical treatment is the only approach with potentially defined clinical success for organic mitral valve (MV) regurgitation. Recurrent or persistent complaints after initial successful MV repair is a clinical challenge in current practice. Especially when echo parameters at rest are within or near normal ranges and patients presenting disproportionately symptomatic in relation to the observed results. However, while MV regurgitation is a hemodynamic disease, currently used 2-dimensional (2D) transthoracic echocardiography (TTE) at rest lacks information about hemodynamic changes. Physical stress echocardiography is a promising technique to complement nowadays rest TTE in order to improve interpretation of hemodynamic changes. However, normal values for exercise echo are lacking in this postoperative patients cohort. A prospective, observational trial to determine normal values in stress echocardiographic parameters in asymptomatic patients after successful MV repair for organic MV regurgitation, is therefore highly needed.

Purpose of the SEP- study is to determine normal values in stress echocardiographic parameters in asymptomatic patients at least 6 months after successful MV repair for organic MV regurgitation. These normal values for stress echo are of utmost importance to correctly and accurate interpret stress echo results during postoperative follow-up and to improve clinical decision making in patients post MV repair.

Study Overview

Study Type

Observational

Enrollment (Actual)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Utrecht, Netherlands, 3584 CX
        • University Medical Center Utrecht (UMC Utrecht)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

25 Asymptomatic patients (≥18 years) at least 6 months after successful MV repair. Patients will have a LVEF ≥45%, and were initially operated based on organic MV regurgitation.

Description

Inclusion Criteria:

  • Age ≥18 years;
  • Male or female from all ethnicities;
  • At least 6 months post successful, isolated MV repair. S
  • Asymptomatic

Exclusion Criteria:

  • Pulmonary hypertension >50 mmHg at rest;
  • Atrial fibrillation (AF) at time of study related stress echo test;
  • Known contraindication or incapability to perform peak exercise or inability to perform physical stress testing;
  • LVEF <45%;
  • NYHA class II and more.
  • Other heart valve disease of more than mild severity;
  • Concomitant surgery during MV repair, e.g. MAZE, TVP procedure;
  • Prior heart valve surgery;
  • Congenital heart disease;
  • Disabling comorbidity, e.g. chronic obstructive pulmonary disease (COPD);
  • Unable to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Echocardiographic parameter: Peak mitral valve mean gradient (mmHg)
Time Frame: at least 6 months after successful MV repair
Echocardiographic measured mitral valve mean gradient at peak physical exercise
at least 6 months after successful MV repair
Echocardiographic parameter: Peak systolic pulmonary artery pressure (sPAP, mmHg)
Time Frame: at least 6 months after successful MV repair
Echocardiographic measured sPAP at peak physical exercise
at least 6 months after successful MV repair
Echocardiographic parameter: Increase in mitral valve regurgitation grade (grade 0-4, according to ESC guidelines)
Time Frame: at least 6 months after successful MV repair
Echocardiographic measured increase in mitral valve regurgitation at peak physical exercise during physical stress echo, compared to rest echo. Grading of mitral regurgitation will be performed according to the ESC guidelines.
at least 6 months after successful MV repair

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Echocardiographic parameter: Left ventricular function (LVF, quality description)
Time Frame: at least 6 months after successful MV repair
Echocardiographic measured LVF quality at rest and peak physical exercise
at least 6 months after successful MV repair
Echocardiographic parameter: Mitral valve area (MVA, cm2)
Time Frame: at least 6 months after successful MV repair
Echocardiographic measured MVA at rest and peak physical exercise
at least 6 months after successful MV repair
Echocardiographic parameter: Peak mitral valve peak gradient (mmHg)
Time Frame: at least 6 months after successful MV repair
Echocardiographic measured mitral valve peak gradient at peak physical exercise
at least 6 months after successful MV repair

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Steven AJ Chamuleau, MD, PhD, UMC Utrecht

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2014

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

October 7, 2014

First Submitted That Met QC Criteria

February 19, 2015

First Posted (Estimate)

February 26, 2015

Study Record Updates

Last Update Posted (Estimate)

December 29, 2015

Last Update Submitted That Met QC Criteria

December 27, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • NL39865.041.14

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Valve Diseases

Subscribe